SAINTE-FOY, QUEBEC--(MARKET WIRE)--Aug 20, 2007 -- Bioxel Pharma Inc. (CDNX:BIP.V - News), a leading manufacturer of taxane active pharmaceutical ingredients (APIs) and developer of targeted oncology drugs, today announced its results for the second quarter ended June 30, 2007.
